Cargando...
Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is now the most common chronic liver disease in the United States, affecting approximately 1 out of every 4 Americans. NAFLD is a spectrum of disorders including simple steatosis, characterized by the presence of hepatic steatosis with minimal inflammation,...
Guardado en:
| Publicado en: | Metabolism |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7529729/ https://ncbi.nlm.nih.gov/pubmed/32387227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.metabol.2020.154259 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|